Ricart E - Search Results

1

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.

Ricart E, Panaccione R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Inflamm Bowel Dis. 2004 May;10(3):207-14. doi: 10.1097/00054725-200405000-00005. Inflamm Bowel Dis. 2004. PMID: 15290913

2

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541

3

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Am J Gastroenterol. 2002 Jul;97(7):1763-8. doi: 10.1111/j.1572-0241.2002.05838.x. Am J Gastroenterol. 2002. PMID: 12135032

4

Management of Crohn's disease of the ileoanal pouch with infliximab.

Colombel JF, Ricart E, Loftus EV Jr, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ. Colombel JF, et al. Among authors: ricart e. Am J Gastroenterol. 2003 Oct;98(10):2239-44. doi: 10.1111/j.1572-0241.2003.07675.x. Am J Gastroenterol. 2003. PMID: 14572574

5

Risk factors and characteristics of extent progression in ulcerative colitis.

Etchevers MJ, Aceituno M, García-Bosch O, Ordás I, Sans M, Ricart E, Panés J. Etchevers MJ, et al. Among authors: ricart e. Inflamm Bowel Dis. 2009 Sep;15(9):1320-5. doi: 10.1002/ibd.20897. Inflamm Bowel Dis. 2009. PMID: 19235909

6

Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.

Rimola J, Rodríguez S, García-Bosch O, Ricart E, Pagès M, Pellisé M, Ayuso C, Panés J. Rimola J, et al. Among authors: ricart e. Radiographics. 2009 May-Jun;29(3):701-19. doi: 10.1148/rg.293085115. Radiographics. 2009. PMID: 19448111 Review.

7

[Psychology and inflammatory bowel disease].

Ginard D, Ricart E. Ginard D, et al. Among authors: ricart e. Gastroenterol Hepatol. 2009 Oct;32 Suppl 2:1-2. doi: 10.1016/S0210-5705(09)72597-X. Gastroenterol Hepatol. 2009. PMID: 19900620 Spanish. No abstract available.

8

New MRI modalities for assessment of inflammatory bowel disease.

Panés J, Ricart E, Rimola J. Panés J, et al. Among authors: ricart e. Gut. 2010 Oct;59(10):1308-9. doi: 10.1136/gut.2010.214197. Epub 2010 Jul 30. Gut. 2010. PMID: 20675700 No abstract available.

9

[Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?].

Ricart E, Panés J, Benítez-Ribas D. Ricart E, et al. Gastroenterol Hepatol. 2011 Feb;34(2):100-6. doi: 10.1016/j.gastrohep.2010.10.011. Epub 2011 Feb 17. Gastroenterol Hepatol. 2011. PMID: 21333391 Spanish.

10

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

Rimola J, Ordás I, Rodriguez S, García-Bosch O, Aceituno M, Llach J, Ayuso C, Ricart E, Panés J. Rimola J, et al. Among authors: ricart e. Inflamm Bowel Dis. 2011 Aug;17(8):1759-68. doi: 10.1002/ibd.21551. Epub 2010 Nov 8. Inflamm Bowel Dis. 2011. PMID: 21744431 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results